[Skip to Content]
JAMA Network Home
JAMA
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
New Online Current Issue Past Issues

June 2019 - July 1883

Decade

Year

Issue

June 8, 2011, Vol 305, No. 22, Pages 2257-2368 | Cancer

Preliminary Communication

KIT as a Therapeutic Target in Metastatic Melanoma

Richard D. Carvajal, MD; Cristina R. Antonescu, MD; Jedd D. Wolchok, MD, PhD; et al.
Abstract Full Text
free access
JAMA. 2011;305(22):2327-2334. doi:10.1001/jama.2011.746
This Week in JAMA

This Week in JAMA

Abstract Full Text
free access has audio
JAMA. 2011;305(22):2257. doi:10.1001/jama.2011.782
  • Audio Summary: JAMA: 2011-06-08, Vol. 305, No. 22, This Week's Audio Commentary
A Piece of My Mind

Way Back When

Katherine E. Reeder-Hayes, MD, MBA
Abstract Full Text
JAMA. 2011;305(22):2266-2267. doi:10.1001/jama.2011.419
Original Contribution

Effect of Screening on Ovarian Cancer Mortality: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial

Saundra S. Buys, MD; Edward Partridge, MD; Amanda Black, PhD, MPH; et al.
Abstract Full Text
free access
JAMA. 2011;305(22):2295-2303. doi:10.1001/jama.2011.766

Cancer Risks Associated With Germline Mutations in MLH1, MSH2, and MSH6 Genes in Lynch Syndrome

Valérie Bonadona, MD, PhD; Bernard Bonaïti, MSc; Sylviane Olschwang, MD, PhD; et al.
Abstract Full Text
free access
JAMA. 2011;305(22):2304-2310. doi:10.1001/jama.2011.743

Long-term Risks of Subsequent Primary Neoplasms Among Survivors of Childhood Cancer

Raoul C. Reulen, PhD; Clare Frobisher, PhD; David L. Winter; et al.
Abstract Full Text
free access
JAMA. 2011;305(22):2311-2319. doi:10.1001/jama.2011.747

Characteristics of Clinical Trials to Support Approval of Orphan vs Nonorphan Drugs for Cancer

Aaron S. Kesselheim, MD, JD, MPH; Jessica A. Myers, PhD; Jerry Avorn, MD
Abstract Full Text
free access
JAMA. 2011;305(22):2320-2326. doi:10.1001/jama.2011.769
Editorial

Cancer Risk Assessment in Lynch Syndrome: Does the Gene Matter?

Rosa M. Xicola, PhD; Xavier Llor, MD, PhD
Abstract Full Text
JAMA. 2011;305(22):2351-2352. doi:10.1001/jama.2011.771
Review

Association Between Time to Initiation of Adjuvant Chemotherapy and Survival in Colorectal Cancer: A Systematic Review and Meta-analysis

James J. Biagi, MD; Michael J. Raphael; William J. Mackillop, MB, ChB; et al.
Abstract Full Text
JAMA. 2011;305(22):2335-2342. doi:10.1001/jama.2011.749
Medical News & Perspectives

Debate Continues on Use of PSA Testing for Early Detection of Prostate Cancer

M. J. Friedrich
Abstract Full Text
JAMA. 2011;305(22):2273-2276. doi:10.1001/jama.2011.777

Retinoblastoma Therapy Delivers Power of Chemotherapy With Surgical Precision

M. J. Friedrich
Abstract Full Text
JAMA. 2011;305(22):2276-2278. doi:10.1001/jama.2011.778

Studies Probe Role of Telomere Length in Predicting, Modulating Cancer Risk

Tracy Hampton, PhD
Abstract Full Text
JAMA. 2011;305(22):2278-2279. doi:10.1001/jama.2011.772
News From the Centers for Disease Control and Prevention

Cancer Survivors—United States, 2007

Abstract Full Text
free access
JAMA. 2011;305(22):2281-2282. doi:

Bullying Among Middle School and High School Students—Massachusetts, 2009

Abstract Full Text
free access
JAMA. 2011;305(22):2283-2286. doi:
Capitol Health Call

VA Oversight Questioned

Mike Mitka
Abstract Full Text
JAMA. 2011;305(22):2280. doi:10.1001/jama.2011.773

Measuring Countermeasures

Mike Mitka
Abstract Full Text
JAMA. 2011;305(22):2280. doi:10.1001/jama.2011.774

Quality Improvement

Mike Mitka
Abstract Full Text
JAMA. 2011;305(22):2280. doi:10.1001/jama.2011.775

Device Approval

Mike Mitka
Abstract Full Text
JAMA. 2011;305(22):2280. doi:10.1001/jama.2011.776
Letters

Axillary vs Sentinel Lymph Node Dissection for Invasive Breast Cancer

Ismail Jatoi, MD, PhD
Abstract Full Text
JAMA. 2011;305(22):2288-2291. doi:10.1001/jama.2011.750

Axillary vs Sentinel Lymph Node Dissection for Invasive Breast Cancer

I-Chun Chen, MD; Ching-Hung Lin, MD; Yen-Shen Lu, MD, PhD
Abstract Full Text
JAMA. 2011;305(22):2288-2291. doi:10.1001/jama.2011.751

Axillary vs Sentinel Lymph Node Dissection for Invasive Breast Cancer

Michael D. Hasselle, MD; Paige L. Dorn, MD
Abstract Full Text
JAMA. 2011;305(22):2288-2291. doi:10.1001/jama.2011.752

Axillary vs Sentinel Lymph Node Dissection for Invasive Breast Cancer

Merdan Fayda, MD; Ronald Chen, MD, MPH
Abstract Full Text
JAMA. 2011;305(22):2288-2291. doi:10.1001/jama.2011.753

Axillary vs Sentinel Lymph Node Dissection for Invasive Breast Cancer

Benjamin O. Anderson, MD; Julie R. Gralow, MD
Abstract Full Text
JAMA. 2011;305(22):2288-2291. doi:10.1001/jama.2011.754

Axillary vs Sentinel Lymph Node Dissection for Invasive Breast Cancer

Seenu Vuthaluru, MS; Anurag Srivastava, MS, FRCS, MPhil, PhD
Abstract Full Text
JAMA. 2011;305(22):2288-2291. doi:10.1001/jama.2011.755

Axillary vs Sentinel Lymph Node Dissection for Invasive Breast Cancer—Reply

Armando E. Giuliano, MD; Monica Morrow, MD; Karla V. Ballman, PhD
Abstract Full Text
JAMA. 2011;305(22):2288-2291. doi:10.1001/jama.2011.756

Bevacizumab and Cancer Treatment-Related Mortality

Zu-Yao Yang, MD; Chen Mao, MD; Jin-Ling Tang, MD, PhD
Abstract Full Text
JAMA. 2011;305(22):2291-2293. doi:10.1001/jama.2011.757

Bevacizumab and Cancer Treatment-Related Mortality

Cornelis J. A. Punt, MD, PhD; Linda Mol, MSc; Miriam Koopman, MD, PhD
Abstract Full Text
JAMA. 2011;305(22):2291-2293. doi:10.1001/jama.2011.758

Bevacizumab and Cancer Treatment-Related Mortality

Patricia B. Cerrito, PhD
Abstract Full Text
JAMA. 2011;305(22):2291-2293. doi:10.1001/jama.2011.759

Bevacizumab and Cancer Treatment-Related Mortality—Reply

Shenhong Wu, MD, PhD; Vishal Ranpura, MD; Sanjay Hapani, MD
Abstract Full Text
JAMA. 2011;305(22):2291-2293. doi:10.1001/jama.2011.760

Antibiotic Resistance and the Future

Kanika Deshpande Koirala, MBBS; Sudeep Dhoj Thapa, MBBS
Abstract Full Text
JAMA. 2011;305(22):2293-2294. doi:10.1001/jama.2011.761

Antibiotic Resistance and the Future—Reply

James M. Hughes, MD
Abstract Full Text
JAMA. 2011;305(22):2293-2294. doi:10.1001/jama.2011.762
The Cover

Penumbra

Thomas B. Cole, MD, MPH
Abstract Full Text
JAMA. 2011;305(22):2261. doi:10.1001/jama.2011.770
Poetry and Medicine

For Harriet

Richard Schiffman
Abstract Full Text
JAMA. 2011;305(22):2263. doi:10.1001/jama.2011.654
JAMA Patient Page

Melanoma

Ryszard M. Pluta, MD, PhD; Alison E. Burke, MA; Robert M. Golub, MD
Abstract Full Text
free access
JAMA. 2011;305(22):2368. doi:10.1001/jama.2011.658
Correction

Error in Data Extraction and Analyses in: Treatment-Related Mortality With Bevacizumab in Cancer Patients: A Meta-analysis

Abstract Full Text
free access
JAMA. 2011;305(22):2294. doi:10.1001/jama.2011.763
JAMA Masthead

About This Journal

Abstract Full Text
free access
JAMA. 2011;305(22):2259-2260. doi:10.1001/jama.305.22.2259
Commentary

A Strategic Approach to Therapeutic Cancer Vaccines in the 21st Century

Matthew M. Davis, MD, MAPP; Elias J. Dayoub, BA
Abstract Full Text
JAMA. 2011;305(22):2343-2344. doi:10.1001/jama.2011.814

Balancing Access and Evaluation in the Approval of New Cancer Drugs

Franklin G. Miller, PhD; Steven Joffe, MD, MPH
Abstract Full Text
JAMA. 2011;305(22):2345-2346. doi:10.1001/jama.2011.784

Realigning Incentives for Developing and Pricing New Anticancer Treatments

David H. Howard, PhD
Abstract Full Text
JAMA. 2011;305(22):2347-2348. doi:10.1001/jama.2011.793

Seeing the Future of Cancer-Associated Transcription Factor Drug Targets

Panagiotis A. Konstantinopoulos, MD, PhD; Athanasios G. Papavassiliou, MD, PhD
Abstract Full Text
JAMA. 2011;305(22):2349-2350. doi:10.1001/jama.2011.727
JAMA 100 Years Ago

A Preliminary Report on the Mortality of Cancer in the United States, as Given by the Census of 1910

Abstract Full Text
JAMA. 2011;305(22):2359. doi:10.1001/jama.2011.737
Book and Media Reviews

Cancer Genetics

Charis Eng, MD, PhD
Abstract Full Text
JAMA. 2011;305(22):2353. doi:10.1001/jama.2011.794

Adult Acute Lymphocytic Leukemia: Biology and Treatment

Paulette Mehta, MD, MPH
Abstract Full Text
JAMA. 2011;305(22):2353-2358. doi:10.1001/jama.2011.795

From Dark Night to Gentle Surrender: On the Ethics and Spirituality of Hospice Care

Michael D. Barnett, MD
Abstract Full Text
JAMA. 2011;305(22):2353-2358. doi:10.1001/jama.2011.796

Hope in the Age of Anxiety

Elaine C. Meyer, PhD, RN
Abstract Full Text
JAMA. 2011;305(22):2353-2358. doi:10.1001/jama.2011.797

The Emperor of All Maladies: A Biography of Cancer

Paulette Mehta, MD, MPH
Abstract Full Text
JAMA. 2011;305(22):2357-2358. doi:10.1001/jama.2011.798
Most Viewed(30 Days) RSS link
Most Cited(3 Years) RSS Link
×
Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our cookie policy | Continue